PRISCIANDARO, MICHELE

PRISCIANDARO, MICHELE  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 1-gen-2021 Manca P.Sartore Bianchi A.Randon G.Prisciandaro M.Pietrantonio F. + Article (author) -
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients : the AMNESIA Case-Control Study 1-mar-2018 F. PietrantonioG. FucàA. V. GualeniC. C. VolpiM. PrisciandaroG. PruneriF. de Braud + Article (author) -
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 9-apr-2020 Prisciandaro M.Sposito C.Mazzaferro V.de Braud F.Pietrantonio F. + Article (author) -
Differential histopathologicparameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials 1-apr-2018 A. MennittoM. PrisciandaroA. PellegrinelliF. de BraudV. MazzaferroF. Pietrantonio + Article (author) -
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? 1-set-2017 E. VerzoniM. PrisciandaroA. MennittoF. de Braud + Article (author) -
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 1-gen-2020 Pietrantonio FRandon GRaimondi APagani FPrisciandaro MCorti FMarra ACurigliano Gde Braud F. + Article (author) -
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram 1-gen-2018 F. PietrantonioG. FucàM. PrisciandaroF. de Braud + Article (author) -
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 13-feb-2019 Indini, AlicePrisciandaro, MicheleRandon, GiovanniDe Braud, Filippo + Article (author) -
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 1-gen-2021 Manca P.Corallo S.Randon G.Tomasello G.Prisciandaro M.Di Bartolomeo M.de Braud F.Pietrantonio F. + Article (author) -
The landscape of actionable gene fusions in colorectal cancer 1-nov-2019 Randon G.Prisciandaro M.Lobefaro R.de Braud F.Pietrantonio F. + Article (author) -
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer 1-giu-2018 C. VernieriA. MennittoM. PrisciandaroF. de Braud + Article (author) -
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 1-gen-2021 Pietrantonio, Filippode Pascale, StefanoRausa, EmanueleSiena, SalvatoreSartore-Bianchi, AndreaPrisciandaro, Michele + Article (author) -
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience 4-dic-2018 Indini, AlicePrisciandaro, MicheleRandon, GiovanniTolomio, ElenaDe Braud, Filippo + Article (author) -
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 1-mar-2019 F. PietrantonioC. CotsoglouG. FucàF. NichettiJ. CoppaA. AlessiM. PrisciandaroM. Droz-Dit BussetS. CoralloA. MennittoG. RandonA. RaimondiB. PadovanoF. PerroneM. Di BartolomeoF. de BraudV. Mazzaferro + Article (author) -
Personalized therapeutic strategies in HER2-driven gastric cancer 23-mar-2021 Pietrantonio, FilippoDe Pascale, StefanoRausa, EmanueleSiena, SalvatoreSartore-Bianchi, AndreaRaimondi, AlessandraPrisciandaro, Michele + Article (author) -
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 1-apr-2021 Corti, FrancescaAmbrosini, MargheritaManca, PaoloRaimondi, AlessandraPrisciandaro, MicheleCurigliano, GiuseppeDe Braud, FilippoDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials. 1-gen-2020 Prisciandaro MDe Braud FPietrantonio F + Article (author) -
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 1-gen-2021 Sartore-Bianchi A.Prisciandaro M.Pietrantonio F. + Article (author) -
Recent Advances in the Management of Typical and Atypical Lung Carcinoids 1-mag-2021 Rossi R. E.Torchio M.Prisciandaro M.Spreafico C.Beninato T.de Braud F. + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 1-lug-2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -